Skip to main content

Diabetes

  • DiabetesSisters kicks off campaign aimed at diabetic women

    RALEIGH, N.C. A nonprofit that seeks to improve the health and quality of life of women with — and those at risk of developing — diabetes has kicked off a national campaign.

     

    DiabetesSisters said that its OrangeWill campaign represents the will and determination required for women to manage their diabetes on top of their many other responsibilities.

     

     

  • Biodel receives complete response letter for Linjeta

    DANBURY, Conn. The Food and Drug Administration has turned down an application for an insulin product made by Biodel, Biodel said.

     

    The drug maker announced that it received a complete response letter from the FDA for Linjeta (human insulin [rDNA origin]) for the treatment of Type 1 and Type 2 diabetes.

     

     

  • Tolerx's scientific advisory board to advance Type 1 diabetes research

    CAMBRIDGE, Mass. A company that develops drugs for treating autoimmune diseases and cancer has created a scientific advisory board as part of its efforts to create treatments for Type 1 diabetes.

     

    Tolerx said the four-member board would support the development of its lead drug candidate, otelixizumab, and guide future research and development in the Type 1 diabetes area.

     

     

  • Study questions accuracy of health info shared through social media

    WOONSOCKET, R.I. A recent study of diabetes information shared on Facebook raised questions about the accuracy of the information on social media sites and its sources, according to the research sponsored by CVS Caremark.

     

  • Wegmans introduces co-branded glucose monitoring system with Nipro

    ROCHESTER, N.Y. Wegmans on Monday announced the availability of its co-branded blood-glucose monitoring systems: Nipro Diagnostics’ TrueResult system and True2go.

     

  • Survey reveals lifestyle habits among diabetes patients

    WOONSOCKET, R.I. CVS/pharmacy on Monday announced results of a survey examining various aspects of disease management and lifestyle for patients with diabetes. Of 3,242 respondents with diabetes, 32% reported they have been less vigilant about daily glucose testing due to cost, and as many as 24% of respondents said that cost has led them to be less conscientious about maintaining a proper diet.

  • Diabetes should be focus of healthcare professionals year-round

    WHAT IT MEANS AND WHY IT’S IMPORTANT There are many pharmacy retailers hooking their diabetes-related initiatives into the awareness generated by American Diabetes Month, but judging by a new study recently issued by the Centers for Disease Control and Prevention, it may be time for healthcare professionals to begin piecing together initiatives that will help maintain that heightened awareness over the course of an entire year.

X
This ad will auto-close in 10 seconds